Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy - 1 Jan 2022

Bueschbell Beatriz, Caniceiro Ana Beatriz, Suzano Pedro M S, Machuqueiro Miguel, Rosário-Ferreira Nícia, Moreira Irina S

Abstract excerpt

Globally with over 10 million deaths per year, cancer is the most transversal disease across countries, cultures, and ethnicities, affecting both developed and developing regions. Tumorigenesis is dynamically altered by distinct events and can be lethal when untreated. Despite the innovative therapeutics available, multidrug resistance (MDR) to chemotherapy remains the major hindrance to the success of cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Artificial Intelligence
Share to Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Multiple

Share to Neoplasms

Share to Phenotype

Source

Identifiers

PMID: 35121338
DOI: 10.1016/j.drup.2022.100811

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Network biology and artificial intelligence drive the understanding of the multidrug resistance phenotype in cancer.PMID 35121338Read ↗

Artificial intelligence in tumor drug resistance: Mechanisms and treatment prospectsSemantic proximity Read ↗

Artificial Intelligence–Driven Identification of Multidrug Resistance Genes in Cancer GenomicsSemantic proximity Read ↗

Artificial Intelligence–Driven Identification of Multidrug Resistance Genes in Cancer GenomicsSemantic proximity Read ↗

Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challengesSemantic proximity Read ↗

Artificial Intelligence to Decode Cancer Mechanism: Beyond Patient Stratification for Precision OncologySemantic proximity Read ↗

Managing Drug Resistance in Cancer: Role of Cancer Informatics.Semantic proximity Read ↗

Artificial intelligence assists precision medicine in cancer treatmentSemantic proximity Read ↗

Precision Oncology in the Era of Genomics and Artificial IntelligenceSemantic proximity Read ↗

Genomics and Cancer Drug ResistanceSemantic proximity Read ↗

Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncologySemantic proximity Read ↗

Circumventing Cancer Drug Resistance in the Era of Personalized MedicineSemantic proximity Read ↗

Multi-omics data integration reveals molecular mechanisms of carfilzomib resistance in multiple myelomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.